# Element Materials Technology Pharma USA LLC - Inspection Records

Source: https://www.keypedia.com/companies/element-materials-technology-pharma-usa-llc/d40408f6-37dd-44fb-8760-20aa927a8e8c

> Inspection records and compliance data for Element Materials Technology Pharma USA LLC in Santa Fe Springs, California. Access full analysis and detailed observations.

---

## Details

- Name: Element Materials Technology Pharma USA LLC
- FEI Number: 3000203007
- City: Santa Fe Springs
- State: California
- Country Name: United States
- Address Line 1: 9240 Santa Fe Springs Rd
- Zip Code: 90670
- Business Operations: API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1268807 - Element Materials Technology Pharma USA LLC - 2025-03-28](https://www.keypedia.com/records/fda_inspections/element-materials-technology-pharma-usa-llc/bc0acc3f-2526-4c02-8076-f06070bbb801) — source: FDA, date: March 28, 2025
- [FDA Inspection 1268807 - Element Materials Technology Pharma USA LLC - 2025-03-28](https://www.keypedia.com/records/fda_inspections/element-materials-technology-pharma-usa-llc/1506bcc0-0c89-43fa-ad8d-f80f5d9f09d0) — source: FDA, date: March 28, 2025
- [FDA Inspection 1268807 - Element Materials Technology Pharma USA LLC - 2025-03-28](https://www.keypedia.com/records/fda_inspections/element-materials-technology-pharma-usa-llc/78901b98-85c0-46dd-ae29-31bb1f449327) — classification: No Action Indicated (NAI), source: FDA, date: March 28, 2025
- [FDA Inspection 1268807 - Element Materials Technology Pharma USA LLC - 2025-03-28](https://www.keypedia.com/records/fda_inspections/element-materials-technology-pharma-usa-llc/a3551323-16e6-4523-8afa-2c2c7637aa62) — classification: No Action Indicated (NAI), source: FDA, date: March 28, 2025
- [FDA Inspection 1224702 - Element Materials Technology Pharma USA LLC - 2023-11-08](https://www.keypedia.com/records/fda_inspections/element-materials-technology-pharma-usa-llc/def773ff-8cdb-404e-ba7a-78e6a7946e3d) — classification: No Action Indicated (NAI), source: FDA, date: November 8, 2023
- [FDA Inspection 1088621 - Element Materials Technology Pharma USA LLC - 2019-05-03](https://www.keypedia.com/records/fda_inspections/element-materials-technology-pharma-usa-llc/e5d3dd66-061c-49f8-ae56-38d81c721c4c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2019
- [FDA Inspection 1088621 - Element Materials Technology Pharma USA LLC - 2019-05-03](https://www.keypedia.com/records/fda_inspections/element-materials-technology-pharma-usa-llc/60ff25bf-4fd6-49e1-9669-5434f4fba191) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2019
- [FDA Inspection 1061760 - Element Materials Technology Pharma USA LLC - 2018-08-01](https://www.keypedia.com/records/fda_inspections/element-materials-technology-pharma-usa-llc/c7367a43-b3c6-4088-a0b8-36f083f2ed96) — classification: No Action Indicated (NAI), source: FDA, date: August 1, 2018
- [FDA Inspection 965654 - Element Materials Technology Pharma USA LLC - 2016-03-25](https://www.keypedia.com/records/fda_inspections/element-materials-technology-pharma-usa-llc/767d2558-6ba6-4290-a770-3c025236a3a0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2016
- [FDA Inspection 965654 - Element Materials Technology Pharma USA LLC - 2016-03-25](https://www.keypedia.com/records/fda_inspections/element-materials-technology-pharma-usa-llc/23b9f761-7d54-4644-adf4-66d842552f51) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2016

## Related Companies

- [Fougera Pharmaceuticals  Inc.](https://www.keypedia.com/companies/fougera-pharmaceuticals-inc/3868bd8e-22c5-4998-85b0-38e0df2d115b)
- [Particle Technology Group, LLC](https://www.keypedia.com/companies/particle-technology-group-llc/739b37e7-35ae-45aa-a515-a9d4d01fccb7)
- [QualTech Laboratories, Inc.](https://www.keypedia.com/companies/qualtech-laboratories-inc/7cf9f443-ef52-4807-8a49-2322da5f4133)
- [American Regent, Inc.](https://www.keypedia.com/companies/american-regent-inc/9e5e908d-150e-4cb7-9d39-ab0eef6c4c0e)
- [Eurofins Biolab S.r.l.](https://www.keypedia.com/companies/eurofins-biolab-srl/3f1b31b8-2af2-4083-8cdb-3e0fbf994b22)
- [Eurofins BioPharma Product Testing Columbia, LLC](https://www.keypedia.com/companies/eurofins-biopharma-product-testing-columbia-llc/b616a9a6-094c-4f02-80ba-59880916eaf2)
- [R.D. Laboratories Inc.](https://www.keypedia.com/companies/rd-laboratories-inc/b75c7a7e-9454-4127-add6-6107232599f1)
- [LabCorp Early Development Laboratories Limited.](https://www.keypedia.com/companies/labcorp-early-development-laboratories-limited/4f0ec845-b78a-440d-b747-30df285f57ad)
- [Eurofins Ams Laboratories Pty Limited](https://www.keypedia.com/companies/eurofins-ams-laboratories-pty-limited/74537d96-5f56-4d70-894c-6869cae9677d)
- [SGS Institut Fresenius GmbH](https://www.keypedia.com/companies/sgs-institut-fresenius-gmbh/9053e3ca-148d-4280-ac0d-789a34084eb8)